Home › Funds › Venrock Adviser, LLC › ORIC

Venrock Adviser, LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

Venrock Adviser, LLC reported holding 4,319,765 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$46.8M, representing 1.42% of its reported portfolio and ranking #16 among its reported holdings. Venrock Adviser, LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.32M sh
Reported value held$46.78M
Portfolio Weight1.42%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's ORIC position evolved

Venrock Adviser, LLC first disclosed a stake in ORIC in Q3 2023 at 2,142,856 shares (US$13.0M). The position peaked in Q3 2025 at 6,596,885 shares, worth US$79.2M. Across 12 filings, Venrock Adviser, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,319,765 shares valued at US$46.8M. Notable position changes include a 81% increase in Q1 2024 (shares fell 49% over the following quarter), a 28% trim in Q1 2025 (shares rose 82% over the following quarter), a 107% increase in Q2 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.14M $12.96M New
Q4 2023 2.43M $22.34M Add
Q1 2024 4.39M $60.42M Add
Q2 2024 4.39M $31.07M Hold
Q3 2024 4.39M $45.04M Hold
Q4 2024 4.39M $35.46M Hold
Q1 2025 3.18M $17.76M Reduce
Q2 2025 6.60M $66.96M Add
Q3 2025 6.60M $79.16M Hold
Q4 2025 5.68M $46.43M Reduce
Q1 2026 4.32M $54.73M Reduce
Q2 2026 4.32M $46.78M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has Venrock Adviser, LLC held ORIC?

Venrock Adviser, LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Venrock Adviser, LLC's current position in ORIC?

As of Q2 2026, Venrock Adviser, LLC holds 4.32M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $46.78M, representing 1.42% of its reported portfolio and ranking #16.

Has Venrock Adviser, LLC been buying or selling ORIC?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in ORIC. The position peaked in Q3 2025 at 6.60M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.